Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

December 31, 2001

Conditions
Cancer
Interventions
DRUG

aminocamptothecin colloidal dispersion

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER